Anti-Selectin Blocker for Liver Ischemic Injury
Small Business Information
BIOMEDICA MANAGEMENT CORPORATION
135 WEST 41ST STREET SUITE 608, NEW YORK, NY, 10036
AbstractDESCRIPTION (provided by applicant): Our objective is to develop a new treatment that will prevent or decrease the tissue damage caused by neutrophil infiltration after ischemia/reperfusion (I/R), which occurs as the result of stroke, coronary isc
* information listed above is at the time of submission.